Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 3, 1996, Pages 446-451

  Franceschi, Maja ^a   Kusić, Zvonko ^b   Franceschi, Dinko ^b   Lukinac, Ljerka ^b   Rončević, Sanja ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b NONE

Author keywords

Iodine 131; Neck ultrasonography; Thyroglobulin; Thyroid carcinoma; Whole body scintigraphy

Indexed keywords

IODINE 131; THYROGLOBULIN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER RECURRENCE; ECHOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CHILD; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS;

EID: 0029961739     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Robbins J Thyroid suppression therapy for prevention of thyroid rumors after radiation exposure In: Degroot LJ, Frohman L, Kaplan EL, Refetoff S. eds Radiation-associated thyroid carcinoma. New York Grune & Stratton, Inc ,1977:419-431
2. McDougall RI. Thyroid scintigraphy In Braverman LE, Utiger RD, eds Werner and Ingbar's the thyroid a fundamental and clinical text Philadelphia: JB Lippincot Company;1991:445-462.
3. Van Herle AJ, Uller RP, Matthews ML, Brown J. Radioimmunoassay for measurement of thyroglobulin in human serum J Clin Invest 1973,52 1320-1327.
4. Van Herle AJ, Uller RP. Elevated serum thyroglobulin A marker of metastases in differentiated thyroid carcinoma. J Clin Invest 1975,56:272-277
5. Ashcraft MW, Van Herle AJ The comparative value of serum thyroglobulin measurements and iodine-131 total-body scans in the follow-up of patients with treated differentiated thyroid cancer Am J Med 1981;71:806-813.
6. Schlumberger M, Fragu P, Paramentier C, Tubiana M. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas, comparison of its value m patients with or without normal residual tissue Acta Endocrinol (Copenh) 1981;98.215-221
7. Black EG, Gimlette TMD, Maisey MN, Cassoni A, Harmer CL, Oates GD Serum thyroglobulin in thyroid cancer. Lancet 1981;2 443-445
8. Blahd WH, Drickman MV, Porter CW, Hill VA, Baumgartner WA. Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy, concise communication. J Nucl Med 1984,25 673-676
9. Pacini F, Lan R, Mazzeo S, Grasso L, Taddei D, Pinchera A Diagnostic value of a single thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol 1985;23 405-411
10. Shephard MC. Serum thyroglobulin and thyroid cancer. Q J Med 1986;229:429-433
11. Black EG, Sheppard MC, Hoffenberg R. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol 1987,27.115-120
12. Lubin E, Mechlis-Frish S, Zatz S, et al Serum thyroglobulin and iodine-131 whole-body scan m the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994;35:257-262.
13. Schneider AB, Bruce RL, Goldman JM, Robins J. Sequential serum thyroglobulin determination Iodine-131 scans and I-131 uptakes after triiodothyronine withdrawal in patients with thyroid cancer J Clin Endocrinol Metab 1981;53:1199-1206.
14. Müller-Gärtner HW, Schneider C Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer Cancer 1988;61:976-981
15. Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma J Nucl Med 1988;29:1515-1520.
16. Aiello DP, Manni A Thyroglobulin measurement versus iodine-131 total-body scan for follow-up of well-differentiated thyroid cancer Arch Intern Med 1990;150:437-439.
17. Girelli ME, Busnardo B, Amerio R, Casara A, Betterle C, Piccolo M Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus thyroglobulin levels after hormone withdrawal and total body scan: results in 291 patients with thyroid cancer. Eur J Nucl Med 1986,11 333-335.
18. Dadparvar S, Krishna L, Brady LW, et al The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma Cancer 1993,71 3767-3673
19. Ronga G, Fiorentine A, Paserio E, et al Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the postsurgical follow-up of differentiated thyroid carcinoma? J Nucl Med 1990.31.1766-1771.
20. Schlumberger M, Tubiana M, De Vathaire F, et al Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986,63:960-967.
21. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels J Nucl Med 1987;28.1888-1981.
22. Schlumberger M, Arcangioli O, Pierkarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patient with normal chest x-ray J Nucl Med 1988;29:1790-1794
23. Schlumberger M, Fragu P, Gardet P, Lumbroso J, Violot D, Permantier C. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients Eur J Nucl Med 1991;18:153-157.
24. Brendel AJ, Lambert B, Guyot M, et al Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow-up of differentiated thyroid carcinoma Eur J Nucl Med 1990;16:35-38.
25. Ramanna L, Waxman A, Braunstein G Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 1991;32:441-446.
26. Edmonds CJ, Kermode JC Thyrotropin receptors, tumor radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers Br J Cancer 1985;52:537-541
27. Simeone JF, Daniels GH, Hall DA, et al Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR 1987;148.45-49.
28. Antonelli A, Miccoli P, Ferdeghini M, et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer Thyroid 1995;5:25-28
29. Schuelfhout LJ, Creutzberg CL, Hamming JF, et al Multivariate analysis of survival in differentiated thyroid cancer the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988;24:331-337.
30. Mazzaferri EL. Radioiodine and other treatment and outcomes In: Braverman LE, Utiger RD, eds Werner and Ingbar's the thyroid, a fundamental and clinical text Philadelphia. JB Lippincot Company, 1991 1138-1165.
31. Franceschi M, Lukinac Lj, Kusić Z, Spaventi Š. A decade of experience in the follow-up of patients with differentiated thyroid carcinoma by thyroglobulin determination [Abstract] Eur J Nucl Med 1990,16 S103.
32. 201Tl scintigraphy and neck ultrasonography m the follow-up of patients with differentiated thyroid carcinoma [Abstract]. Eur J Nucl Med 1992;19.700.
33. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma, a retrospective analysis of surgical outcome using novel prognostic scoring system. Surgery 1987;102 1088-1095
34. Cady B, Rossi R An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988,104:947-953.
35. Ross DS. Long-term management of differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990,19:719-739